Henry Schein announced that the company will present at the following investor conferences:
- Piper Sandler’s 34th Annual Healthcare Conference at the Lotte New York Palace on November 30, 2022, at 9:00 a.m. Eastern time.
- Evercore ISI HealthCONx Virtual Conference on December 1, 2022, at 11:20 a.m. Eastern time.
- Nasdaq 47th Investor Conference at the May Fair Hotel, London, on December 6, 2022, at 10:30 a.m. GMT / 5:30 a.m. Eastern time.
Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts.
Replays will be available on the Henry Schein website following the presentations.
About Henry Schein, Inc.
The company is invested in solutions for health care professionals powered by a network of people and technology. With approximately 22,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
The company operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, the company is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company’s sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.